WASHINGTON — The Jan. 6 committee report's appendix on the intelligence and law enforcement failures ahead of the Jan. 6 attack highlights new information about missed warning signs but stops short of ...
MELBOURNE, Australia and SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results